Vericel Corp reports results for the quarter ended in December - Earnings Summary

Vericel

29/02/2024 15:24

* Vericel Corp  VCEL.OQ  reported quarterly adjusted
earnings of
26 cents​​ per share for the quarter ended in December, higher
than the same quarter last year, when the company reported EPS
of 12 cents.  The mean expectation of six analysts for the
quarter was for earnings of 17 cents per share. Wall Street
expected results to range from 14 cents to 20 cents per share.
    * Revenue rose 23.3% to $65.00 million from a year ago;
analysts
expected $64.52 million. 
    * Vericel Corp's reported EPS for the quarter was 26 cents​.
    * The company reported quarterly net income of $12.99
million.
    * Vericel Corp shares had risen by 34.2% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 18.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "strong buy"

Wall Street's median 12-month price target for Vericel Corp is
$46.50 
This summary was machine generated from LSEG data February 29 at
03:22 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.17           0.26           Beat
 Sep. 30 2023      -0.12          -0.08          Beat
 Jun. 30 2023      -0.15          -0.11          Beat
 Mar. 31 2023      -0.15          -0.16          Missed